Cellid Co., Ltd.
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
299660 | KO
Overview
Corporate Details
- ISIN(s):
- KR7299660001
- LEI:
- Country:
- South Korea
- Address:
- 서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시
- Website:
- http://www.cellid.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cellid Co., Ltd. is a research and development-focused biotechnology company specializing in immunotherapeutic vaccines for cancer and infectious diseases. The company's core business is centered on its proprietary technology platforms. Its key offering, CeliVax, is an anti-cancer immunotherapeutic vaccine platform that utilizes a patient's own B cells and monocytes, designed to be applicable to any cancer with identified antigens. In addition, Cellid has developed an adenovirus vector-based platform for creating preventive vaccines against infectious diseases, notably used in the development of a COVID-19 vaccine. The company's pipeline is focused on leveraging these technologies to address significant unmet medical needs in oncology and virology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 8.3 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1015.8 KB | ||
| 2025-08-12 00:00 |
Legal Proceedings Report
소송등의판결ㆍ결정(일정금액이상의청구)
|
Korean | 7.0 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 28.4 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 25.5 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 25.5 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 25.5 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 27.6 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 26.2 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 27.6 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 26.2 KB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.2 KB |
Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cellid Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
